ENTITY

Exact Sciences (EXAS US)

39
Analysis
Health CareUnited States
Exact Sciences Corp., is focused on developing and commercializing a non-invasive molecular screening test for the early detection and prevention of colorectal cancer. The Company's test is a stool-based DNA test that identifies both pre-cancer and cancer by detecting genetic mutations in colorectal cancer cells.
more
bullishExact Sciences
10 Dec 2024 13:00

Exact Sciences: Expansion of the Customer Base & Provider Engagement As A Vital Tool For Growth! - Major Drivers

Exact Sciences Corporation's third-quarter 2024 earnings highlighted both achievements and challenges faced by the company. The overall financial...

Logo
159 Views
Share
bullishExact Sciences
09 Aug 2024 23:00

Exact Sciences Corporation: Expansion into Care Gap Programs & Other Major Drivers

Exact Sciences Corp. recently reported its second quarter 2024 earnings demonstrating strong performance and strategic advancements in its...

Logo
268 Views
Share
bullishExact Sciences
24 May 2024 14:00

Exact Sciences Corporation: Leveraging Health Systems and Electronic Ordering Channels To Catalyze Growth! - Major Drivers

Exact Sciences Corporation's first quarter 2024 earnings. The quarter demonstrated robust performance with first quarter revenue growing by 6% to...

Logo
303 Views
Share
bullishExact Sciences
29 Feb 2024 14:00

Exact Sciences Corporation: Launch Of MRD product OncoDetect & Other New Products! - Major Drivers

Exact Sciences Corporation showcased substantial growth and improved profitability throughout 2023. With a 24% increase in core revenue amounting...

Logo
192 Views
Share
bearishCarvana
30 Jun 2022 09:55

Liquidity Risk Short Candidates: Carvana, Exact Sciences, Inspire Med, Freshpet, Enviva

Liquidity risk short candidates may not be economically viable given cash flows and capital requirements.  This week we flag Carvana, Exact...

Share
x